Lorenzo
Redondo Collazo
![Foto de Lorenzo](/img/nophoto.png)
![Foto de Massachusetts General Hospital](/img/noimage_org.png)
Massachusetts General Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Massachusetts General Hospital (1)
2022
-
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome
Journal of Neurodevelopmental Disorders, Vol. 14, Núm. 1